Abstract
Abstract
Purpose
To examine the prevalence of female sexual dysfunction (FSD), male erectile dysfunction (ED), and the prevalence and correlates of sexual health discussions between early-onset CRC survivors and their health care providers.
Methods
An online, cross-sectional survey was administered in partnership with a national CRC advocacy organization. Respondents (n = 234; diagnosed < 50 years, 6–36 months from diagnosis/relapse) were colon (36.8%) and rectal (63.3%) cancer survivors (62.5% male). The Female Sexual Function Index (FSFI-6) was used to measure FSD, and the International Index of Erectile Function (IIEF-5) was used to measure ED. Survivors reported whether a doctor communicated with them about sexual issues during/after treatment.
Results
Among females (n = 87), 81.6% had FSD (mean FSFI-6 score = 14.3 [SD±6.1]). Among males (n = 145), 94.5% had ED (mean IIEF-5 score = 13.6 [SD±3.4]). Overall, 59.4% of males and 45.4% of females reported a sexual health discussion. Among the total sample, older age of diagnosis and relapse were significantly associated with reporting a discussion, while female sex was negatively associated with reporting a sexual health discussion. Among males, older age at diagnosis and relapse, and among females, older age of diagnosis, were significantly associated with reporting a sexual health discussion.
Conclusion
The prevalence of FSD and ED were high (8 in 10 females reporting FSD, almost all males reporting ED), while reported rates of sexual health discussion were suboptimal (half reported discussion). Interventions to increase CRC provider awareness of patients at risk for not being counseled are needed to optimize long-term health outcomes.
Funder
University of Southern California
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Shah RR, Millien VO, da Costa WL Jr, Oluyomi AO, Suarez MG, Thrift AP “Trends in the incidence of early-onset colorectal cancer in all 50 United States from 2001 through 2017,“ Cancer, vol. 128, no. 2, pp. 299–310, Jan 15 2022, doi: https://doi.org/10.1002/cncr.33916
2. Siegel RL et al (May 2020) Colorectal cancer statistics, 2020. CA Cancer J Clin 70(3):145–164. https://doi.org/10.3322/caac.21601
3. American Cancer Society (2023) “Cancer can affect male sexual desire and response.“ https://www.cancer.org/cancer/managing-cancer/side-effects/fertility-and-sexual-side-effects/sexuality-for-men-with-cancer/treatment-and-desire-and-response.html
4. Stulz A, Lamore K, Montalescot L, Favez N, Flahault C (2020) “Sexual health in colon cancer patients: A systematic review,“ Psychooncology, vol. 29, no. 7, pp. 1095–1104, Jul doi: https://doi.org/10.1002/pon.5391
5. Buccafusca G, Proserpio I, Tralongo AC, Rametta Giuliano S, Tralongo P (Apr 2019) Early colorectal cancer: diagnosis, treatment and survivorship care. Crit Rev Oncol Hematol 136:20–30. https://doi.org/10.1016/j.critrevonc.2019.01.023